The copper chelators DDC and BCS inhibit the antiviral state induced by interferon, with BCS acting by binding noncovalently to IFN molecules and preventing receptor interaction.
Answers are grounded in this paper and cite their sources.
Copper chelators may blunt interferon antiviral effects in models; leaves open relevance to clinical interferon use.
Treatment of mouse L cells with two structurally unrelated chelators of copper ions, diethyldithiocarbamate (DDC) or bathocuproine sulfonate (BCS), completely inhibited the ability of interferon (IFN) to inhibit mengovirus growth. However, mengovirus virions were inactivated by incubation with DDC, and DDC induced a generalized inhibition of cellular RNA and protein synthesis, possibly combined with the inactivation of one or more specific enzymatic activities involved in the establishment or maintenance of the antiviral state. In contrast, BCS had no effect on either cell or virus growth. BCS combined with trace copper ions in the growth medium and the resulting complex prevented IFN from interacting properly with cellular receptors, apparently by binding noncovalently to the IFN molecules. In some cases, IFN was irreversibly inactivated, probably due to oxidation of essential cystein, tyrosine, or tryptophan residues by the (BCS)2Cu2+ complex. BCS was at least as effective as anti-IFN antibody at neutralizing cell-bound IFN, and has a number of advantages over it.
No takes yet. Share an insight, caveat, or question.
Edward H. Simon (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: